Rodney KB Young
CIK 1337831 · CHIEF FINANCIAL OFFICER · last filed 2026-03-05
Rodney KB Young is a CHIEF FINANCIAL OFFICER who has filed 25 SEC Form 4 insider transactions across 2 companies since 2007. Across all open-market trades the lifetime net is −$68.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $412.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$412.8K
2
25
-$68.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. (RAPT) Delisted | CHIEF FINANCIAL OFFICER | 10,084 | $58.01 | $585.0K | $52.6K | 9 | 2025-06-24 |
| STEM | CFO | 56,477 | $7.31 | $412.8K | -$121.2K | 15 | 2013-06-07 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-05 | — | Mixed | −3,304 | $0 | |
| 2025-06-24 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-02-03 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-11-15 | RAPT Therapeutics, Inc. (RAPT) Delisted | Mixed | — | $0 | EDGAR |
| 2024-02-01 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-02 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-12 | RAPT Therapeutics, Inc. (RAPT) Delisted | Buy (P) | +5,000 | $52.6K | EDGAR |
| 2022-02-14 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-01 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-04 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |